Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATURN statin continuation versus discontinuation after lobar intracerebral hemorrhage
2022-002266-33Phase 3Active
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of simvastatin and atorvastatin in intracerebral hemorrhage (ICH) (2 arms), sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Time to recurrent symptomatic intracerebral hemorrhage. Started Jul 2022; status: active.
02
Drugs
simvastatinatorvastatin
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2022-002266-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002266-33.